Latest Derivatives News

Pantoro Gold’s latest infill drilling at Racetrack within the Norseman Project reveals exceptional high-grade continuity, including a spectacular 1,737 g/t gold intercept, underpinning plans to ramp up underground production.

Patagonia Lithium has received an interim technical report confirming promising porosity and lithium assay results from seven wells, setting the stage for a final resource estimate after well eight completion.

Dateline Resources confirms Colosseum as a high-margin gold project with strong BFS economics and pushes rare earth exploration at Music Valley with assays up to 7.1% TREO.

Minerals 260’s Pre-Feasibility Study cements Bullabulling’s status as a high-margin, long-life gold mine with a 38% resource upgrade to 6.2Moz and early construction underway.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Battery Age Minerals has identified multiple priority exploration targets at its Apex Project in Utah, submitted new drilling permits for Austria’s Bleiberg site, finalised a commercial germanium technology licence, and gained entry to a US defense consortium, underpinning its integrated germanium strategy.

Enova Mining has unveiled significant rare earth element mineralisation at its Santo António Do Jacinto Project in Minas Gerais, Brazil, with initial auger drilling returning high-value grades averaging 25% NdPr in near-surface saprolite.

Alligator Energy's drilling campaign at the Samphire Uranium Project has pushed uranium mineralisation 600 metres south of Blackbush, unlocking new ground on the Mullaquana Crown Lease and advancing resource delineation and feasibility efforts.

Patagonia Lithium's Well 8 at the Formentera/Cilon project in Argentina has delivered impressive packer test flow rates up to 705 L/hr at 257m depth, alongside rising specific gravity and total dissolved solids that hint at promising lithium concentrations.

Invex Therapeutics has broadened its preclinical Alzheimer's program with Tessara Therapeutics, while its cash reserves dipped to $4.02 million in Q4 FY26 amid increased research and administrative costs.

Miramar Resources has delivered auger drilling results at its Joy Helen prospect that bolster the case for deeper bedrock drilling, revealing copper-lead anomalies and large alteration halos indicative of a potentially substantial SEDEX-style deposit.

Pure Resources has achieved a key early milestone with Oak Ridge National Laboratory confirming the recovery of heavy rare earth elements from garnet concentrate at its Garnet Hills Project. While still at proof-of-concept stage, this validates the potential for a new source of critical minerals.